LIWANLI — Investor Presentation 2021

Oct 12, 2021

股票代碼(Stock Code)：3054

立萬利創新股份有限公司?LIWANLI Innovation Co., Ltd.?2021年度 法人說明會? Presentation in the year of 2021

免責聲明 Disclaimers

本公司並未發佈財務預測，但本簡報所作有關本公司業務面、財務面及Q&A之說明，若涉及本公司對未來公司經營與產業發展上之見解，可能與未來實際結果存有差距。此差距其造成之原因可能包括市場需求變化、價格波動、競爭行為、國際經濟狀況、匯率波動、上下游供應鏈等其他各種本公司所不能掌握之風險因素。
本簡報是建立於本公司從各項來源所取得之資訊。未來若有變更或調整時，請以公開資訊觀測站公告資訊為主要依據。
LIWANLI Innovation Co., Ltd. does not release any financial forecast. However, the statement of the company’s business, finance condition and Q&A in this presentation may differ from future actual results. This causes from market demand, prices fluctuations, competitions behavior, global economic situations, exchange rate fluctuations, supply chain and other factors or risks beyond the company’s control.

This presentation is based on the information obtained from various sources which the Company believes to be reliable. please refer to the information on MOPS website as the main basis if any adjustment has been made.

Notes:

大 綱 Agenda
公司概況 (Corporate Overview)
營運概況 (Business Overview)
財務概況 (Financial Overview)
未來展望 (Future Vision)

壹、公司概況 Corporate Overview
董 事 長(Chairman):陳立青 (Jason Chen)
公司成立(Date of Established):1991年 6月 (June, 1991)
股票上市(Date of listing in TWSE ):2002年11月 (November, 2002)
股票代號(Stock Code): 3054
實收資本額(Capital):新臺幣8.34億元 (NTD 834 Million)
營業項目:
1.生技相關產品的開發與銷售(Development and sales of biotech related products)
2.電子產品貿易銷售(Electronic products trading sales)

壹、公司概況 Corporate Overview
(Continuing)

壹、公司概況 Corporate Overview
(Continuing)
立萬利創新股份有限公司於自1991年創立以來，一直以秉持著[創新、價值、服務、品質]作爲永續經營之基礎。
Since its establishment in 1991, LIWANLI Innovation Co., Ltd. (the Company) has been basing on its principle of " Innovation, Quality, Service, and Value " for its sustainable development.

立萬利創新股份有限公司原從事電子產品之研發、生產製造、銷售、代工服務及其他事業等全方位及多角化經營方式，但因近年來，電子記憶體相關產業環境持續低迷，為考量未來營運發展及股東權益，並積極開拓新事業及新產品，故於2015年底陸續結束電子記憶體製造等效益毛利不佳之事業並調整組織人力結構。
The Company is operation in electronic products research and development, manufacturing, sales, OEM services and other businesses, such as all-round and diversified management mode. But over the years, electronic memory-related industrial environment continued to slump, To consider future operation and development and shareholders' equity, actively explore new business and new products. Therefore, by the end of 2015, the company decided to end the department of poor profit margins such as manufacturing of electronic memory, at the same adjust the organizational manpower structure.

立萬利創新股份有限公司2021年度起專心致力於積極開發生技新保健品事業體，以期完全轉型跨足生技產業。
From 2021, Liwanli Innovation Co., Ltd. will devote itself to actively developing a new health product business unit with a view to complete transformation across the biotechnology industry.

貳、營運概況 Business Overview

近年來公司主要產品項目及營業比重?(Items and ratio of main products of the Company)

產品別 Category	主要產品項目 Main Products	2019	2020	2021Q2
儲存裝置 Storage products	包括DRAM及FLASH等相關記憶體產品。 DRAM and FLASH of Memory products related.	90%	77%	1%
其他 other	生技及其他產品。Biotechnology products and others.	10%	23%	99%
合 計		100%	100%	100%

貳、營運概況 Business Overview (Continuing)

生技類產品介紹 Biotechnology products-威客維Powder系列

ibSium-HST PROBIOTICS
MaquiBright LUTEIN

PROBIOTIC ENZYME

貳、營運概況 Business Overview (Continuing)

生技類產品介紹 Biotechnology products-威客維Powder系列

PRO-ACTIVE NUTRIENTS
CORDYCEPS MILITARIS POWDER
E-SOOTHING POWDER

貳、營運概況 Business Overview (Continuing)

生技類產品介紹 Biotechnology products-威客維精華飲系列

GOYIONG FE TONIC

RED GRAPE EXTRACT CONTAINS RESVERATROL

貳、營運概況 Business Overview (Continuing)

生技類產品介紹 Biotechnology products-威客維健康錠系列

MILK TABLETS

ORAL CARE TABLETS

貳、營運概況 Business Overview (Continuing)
威客維 ABLS 專利益生菌獲頒Monde Selection特級金獎，黃金蟲草子實體粉包及SP1胜肽營養素獲得銀獎肯定。
Won the Monde Selection premium "gold award and silver award".

參、財務概況 (Financial Overview)

合併營收
Revenue of consolidation
單位：新台幣仟元
Unit: NT$ thousand

參、財務概況 (Financial Overview) (Continuing)

合併營業毛利(損)
Gross profit of consolidation
單位：新台幣仟元
Unit: NT$ thousand

參、財務概況(Financial Overview) (Continuing)

合併營業淨損
(Operation loss of consolidation)

單位：新台幣仟元
Unit: NT$ thousand

參、財務概況(Financial Overview) (Continuing)

合併本期淨利
(Net Income of consolidation)
單位：新台幣仟元
Unit: NT$ thousand

參、財務概況 (Financial Overview) (Continuing)

財務結構 ?Financial Analysis -Consolidated

2020/6/30　　　　　2020/12/31　　　　　2021/6/30
2020/6/30　　　　　2020/12/31　　　　　2021/6/30

參、財務概況(Financial Overview) (Continuing)

簡明合併綜合損益表?(Condensed Statement of Income- Consolidated)

參、財務概況(Financial Overview) (Continuing)

簡明資產負債表?(Condensed Balance Sheet-Consolidated)

公司展望 Future Vision
立萬利創新股份有限公司目前以開發生技產品之買賣為主要營業收入外，未來業務拓展:
The Company mainly trades the trading of health food products as its main business revenue, the main objectives of future business development are as follows

擴展國內外市場以增加公司營業收入
(Expansion of domestic and foreign markets to increase operating income)

積極開發更多保健食品並取得相關認證
(Actively develop more health foods and obtain relevant certification)

自行研發生技類產品，以取得市場之優勢
(Biotechnology research and development products to gain the market advantage)

歡迎各位指教
Q & A

簡報完畢~?Thank you